GFAP and Alzheimer disease: Clinicians must be vigilant to the possible presence of MOG-AD or autoimmune GFAP-A in children when they have a fever of unknown origin, consciousness disturbance, seizures, or visual disturbance and timely performed MOG or GFAP antibody screening to avoid their missed diagnoses.